White Paper

Chinese Regulatory Changes for Human Serum and Plasma Exports Trigger Potential Delays

November 2, 2010

Researchers conducting or planning to conduct clinical trials in China should be aware of new regulatory changes that specifically affect export shipments of human serum and plasma from China and the delays that the new administrative process may create. This free white paper includes a list of these major changes associated with the new regulations.

Download to find out more.